Mylotarg Safety Questions, Mylotarg Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Mylotarg side effects. Check out Health Surveys and Health Polls. If you have questions about Mylotarg, you can post them to our Doctors or Ask Patient Community about Mylotarg.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Mylotarg
Mylotarg Safety Reports
Total Mylotarg reports: 442.Mylotarg FDA safety alerts: No.
Reported deaths: 180 Reported hospitalizations: 286.
Take Mylotarg Side Effects Survey or Share Your Mylotarg Story.
Reported Mylotarg Side Effects: febrile neutropenia, platelet count decreased, anaemia, neutrophil count decreased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, condition aggravated, sepsis, blood alkaline phosphatase increased, disseminated intravascular coagulation.
More About Mylotarg.
Showing 1-50 of 442 Next >
Mylotarg Side Effects Report #5247361-1Physician from JAPAN reported MYLOTARG problem on Feb 15, 2007. Female patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, liver disorder, toxic skin eruption. MYLOTARG dosage: unknown. During the same period patient was treated with FUNGUARD, PREDNISOLONE, TAZOBACTAM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5248543-5
MYLOTARG problem was reported by a Consumer or non-health professional from JAPAN on Feb 09, 2007. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, disease progression, hyperbilirubinaemia, hypokalaemia, hyponatraemia, neutropenic infection, neutrophil count decreased, platelet count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with DIAMOX, DIFLUCAN. Patient died.
Mylotarg Side Effects Report #5251332-9
Physician from JAPAN reported MYLOTARG problem on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5253016-X
MYLOTARG problem was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5254321-3
Physician from JAPAN reported MYLOTARG problem on Feb 21, 2007. Male patient, weighting 141.1 lb, was diagnosed with acute myeloid leukaemia recurrent, pyrexia, prophylaxis, hypertension, pain and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, platelet count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with VOLTAREN, POLYMYXIN B SULPHATE, CONIEL, DIFLUCAN, MORPHINE, GASTER. Patient died on 10/22/2006.
Mylotarg Side Effects Report #5255383-X
MYLOTARG problem was reported by a Physician from JAPAN on Feb 21, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: condition aggravated, disseminated intravascular coagulation, hypoxia, infection, interstitial lung disease, tumour lysis syndrome. MYLOTARG dosage: unknown. During the same period patient was treated with FIRSTCIN, DIOVAN, AMARYL, MELBIN, ORGARAN, FUNGUARD. Patient died on 06/23/2006.
Mylotarg Side Effects Report #5255460-3
Physician from JAPAN reported MYLOTARG problem on Feb 21, 2007. Female patient, weighting 94.80 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, pyrexia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anorexia, electrocardiogram qt prolonged, fungal sepsis, hypokalaemia, platelet count decreased, staphylococcal sepsis, torsade de pointes, ventricular flutter. MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAL, NAUZELIN, SAXIZON, HEPARIN, GATIFLOXACIN, CYTARABINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5255549-9
MYLOTARG problem was reported by a Physician from JAPAN on Feb 22, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, neutrophil count decreased, performance status decreased, pneumonia, pyrexia, white blood cell count increased. MYLOTARG dosage: unknown. During the same period patient was treated with GASTER, ZOLPIDEM TARTRATE, BAKTAR, MUCOSTA, ETODOLAC, PRORENAL. Patient recovered.
Mylotarg Side Effects Report #5256286-7
Physician from JAPAN reported MYLOTARG problem on Feb 23, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: cardiac failure, condition aggravated, neutrophil count decreased, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with VFEND, LASIX, DIAMOX, TIENAM. Patient died on 11/17/2006.
Mylotarg Side Effects Report #5257029-3
MYLOTARG problem was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, diarrhoea, infection, insomnia, gastritis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, c-reactive protein increased, febrile neutropenia, neutrophil count decreased, platelet count decreased, systemic mycosis, white blood cell count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with BIFIDOBACTERIUM BIFIDUM, TOBRACIN, NITRAZEPAM, TIENAM, TAKEPRON, OLOPATADINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5257030-X
Physician from JAPAN reported MYLOTARG problem on Feb 23, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, cellulitis, condition aggravated, diarrhoea, epistaxis, hepatic function abnormal, mucous membrane disorder, neutrophil count decreased, platelet count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with CYTARABINE, KYTRIL, SAXIZON, NOVANTRONE, ITRACONAZOLE, FAMOTIDINE. Patient was hospitalized. Patient died on 09/02/2006.
Mylotarg Side Effects Report #5257031-1
MYLOTARG problem was reported by a Physician from JAPAN on Feb 24, 2007. Male patient, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fibrin degradation products increased, lung infection, obliterative bronchiolitis, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, FIRSTCIN, CIPROFLOXACIN, NORMAL IMMUNOGLOBULIN, TARGOCID, FUNGUARD, PREDONINE. Patient was hospitalized. Patient died on 01/31/2007.
Mylotarg Side Effects Report #5258288-3
Physician from JAPAN reported MYLOTARG problem on Feb 27, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, reflux oesophagitis, liver abscess, constipation and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: enteritis, febrile neutropenia, gastrointestinal haemorrhage. MYLOTARG dosage: unknown. During the same period patient was treated with ISALON, VFEND, PANTOSIN, MAGNESIUM OXIDE, MAGNESIUM OXIDE, NEOPHAGEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5258291-3
MYLOTARG problem was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient, weighting 124.1 lb, was diagnosed with myelodysplastic syndrome, diabetes mellitus non-insulin-dependent, hypothyroidism, folate deficiency, hyperlipidaemia, candidiasis, pyrexia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: mental status changes. MYLOTARG dosage: unknown. During the same period patient was treated with GLYBURIDE, LEVOTHYROXINE, FOLIC ACID, VYTORIN, FLUCONAZOLE, VITAMIN B, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5259036-3
Physician from JAPAN reported MYLOTARG problem on Mar 02, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, condition aggravated, herpes zoster, malaise, platelet count decreased, pleural effusion, pneumonia, pyrexia. MYLOTARG dosage: unknown. During the same period patient was treated with VFEND, MODACIN, MEROPENEM, TARGOCID, BAKTAR, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5259103-4
MYLOTARG problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, neutrophil count decreased, performance status decreased, pneumonia, pyrexia, white blood cell count increased. MYLOTARG dosage: unknown. During the same period patient was treated with GASTER, ZOLPIDEM TARTRATE, BAKTAR, MUCOSTA, ETODOLAC, PRORENAL. Patient recovered.
Mylotarg Side Effects Report #5259682-7
Physician from JAPAN reported MYLOTARG problem on Mar 02, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, body temperature increased, c-reactive protein increased, hypoalbuminaemia, hypoproteinaemia, performance status decreased. MYLOTARG dosage: unknown. During the same period patient was treated with MAXIPIME, FUNGUARD, MEROPEN, ISEPACIN. Patient recovered.
Mylotarg Side Effects Report #5259683-9
MYLOTARG problem was reported by a Physician from JAPAN on Feb 27, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia, sepsis, septic shock, white blood cell count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, FUNGUARD, CYTARABINE, ITRACONAZOLE, OMEGACIN, BAKTAR, METHOTREXATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5260925-4
Physician from JAPAN reported MYLOTARG problem on Feb 28, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, pruritus and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: depression, haemoglobin decreased, hepatic function abnormal, insomnia, memory impairment, neutrophil count decreased, platelet count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with ITRACONAZOLE, GASTER, MUCOSTA, PREDONINE, DECADRON, ISODINE, MYSER. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5263982-4
MYLOTARG problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, neutrophil count decreased, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with LIPOVAS, FLUCONAZOLE, DAUNORUBICIN HYDROCHLORIDE, ENOCITABINE, FAMOTIDINE, MICARDIS. Patient died on 10/03/2006.
Mylotarg Side Effects Report #5263984-8
Physician from UNITED STATES reported MYLOTARG problem on Mar 01, 2007. Female patient, 40 years of age, weighting 141.3 lb, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pneumonitis. MYLOTARG dosage: unknown. During the same period patient was treated with DAUNOMYCIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5264042-9
MYLOTARG problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, interstitial lung disease, neutrophil count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with OMEGACIN, NEUTROGIN, POLYMYXIN B SULPHATE, PARIET. Patient died on 04/24/2006.
Mylotarg Side Effects Report #5265102-9
Physician from JAPAN reported MYLOTARG problem on Mar 08, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia recurrent, hyperlipidaemia, diabetes mellitus, anxiety, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, oral herpes, pseudomonal sepsis, serratia sepsis, stomatitis, thrombocytopenia. MYLOTARG dosage: unknown. During the same period patient was treated with LIPITOR, ACTOS, CONSTAN, PURSENNID, BASEN, BACTRIM, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5265894-9
MYLOTARG problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, sinusitis aspergillus, prophylaxis, hypertension, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, laryngeal oedema, neutropenia, sinusitis aspergillus. MYLOTARG dosage: unknown. During the same period patient was treated with FUNGUARD, VFEND, MUCOSTA, NORVASC, AMOBAN, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5268144-2
Physician from JAPAN reported MYLOTARG problem on Mar 08, 2007. Female patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, lung injury, mouth haemorrhage, platelet count decreased, pseudomonal sepsis, venoocclusive liver disease, white blood cell count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with HYDREA, SULPERAZON, HEPARIN, FUNGUARD, ZOVIRAX, DAUNORUBICIN HYDROCHLORIDE, TOBRACIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5269629-5
MYLOTARG problem was reported by a Physician from JAPAN on Mar 09, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, febrile neutropenia, haemorrhage, hepatic function abnormal, platelet count decreased, white blood cell count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, GASTER, LENOGRASTIM, MEPTIN, LEVOFLOXACIN, DIFLUCAN, AZELASTINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5270234-5
Physician from JAPAN reported MYLOTARG problem on Mar 12, 2007. Female patient, weighting 81.57 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, disseminated intravascular coagulation, hypoalbuminaemia, pneumonia, renal failure. MYLOTARG dosage: unknown. During the same period patient was treated with ISCOTIN, ISEPAMICIN SULPHATE, AMLODIN, STREPTOCOCCUS FAECALIS, FAMOTIDINE, CIPROFLOXACIN, BAKTAR. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5272838-2
MYLOTARG problem was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia, sepsis, septic shock. MYLOTARG dosage: unknown. During the same period patient was treated with VANCOMYCIN, FUNGUARD, CYLOCIDE, ITRACONAZOLE, OMEGACIN, BAKTAR, METHOTREXATE. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5275036-1
Physician from JAPAN reported MYLOTARG problem on Mar 15, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sedation and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, cellulitis, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, herpes simplex, hypoalbuminaemia, mouth haemorrhage. MYLOTARG dosage: unknown. During the same period patient was treated with NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, BAKTAR, MIDAZOLAM, VFEND. Patient was hospitalized. Patient died on 10/15/2006.
Mylotarg Side Effects Report #5276106-4
MYLOTARG problem was reported by a Physician from UNITED STATES on Mar 16, 2007. Female patient, weighting 124.1 lb, was diagnosed with myelodysplastic syndrome, diabetes mellitus non-insulin-dependent, hypothyroidism, folate deficiency, hyperlipidaemia, candidiasis, pyrexia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: disease progression, disorientation, infection, mental status changes, pneumonia fungal, pyrexia. MYLOTARG dosage: unknown. During the same period patient was treated with GLYBURIDE, LEVOTHYROXINE, FOLIC ACID, VYTORIN, FLUCONAZOLE, VITAMIN B, ACETAMINOPHEN. Patient was hospitalized. Patient died on 03/11/2007.
Mylotarg Side Effects Report #5276551-7
Physician from JAPAN reported MYLOTARG problem on Mar 15, 2007. Female patient, weighting 127.9 lb, was diagnosed with acute myeloid leukaemia, osteoporosis, prophylaxis, hypertension, gastritis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, gastrointestinal haemorrhage, haematuria, renal failure acute. MYLOTARG dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, MUCOSTA, BAKTAR, MAGNESIUM OXIDE, TOWAMIN, SELBEX. Patient was hospitalized. Patient died on 07/20/2006.
Mylotarg Side Effects Report #5277365-4
MYLOTARG problem was reported by a Physician from UNITED STATES on Mar 15, 2007. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: bone marrow disorder, granuloma, liver disorder. MYLOTARG dosage: 9 MG/M^2. Patient recovered.
Mylotarg Side Effects Report #5280074-9
Health Professional from UNITED STATES reported MYLOTARG problem on Mar 26, 2007. Male patient, 68 years of age, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: chills, hypersensitivity, hypertension, hypoxia, pyrexia, tachycardia. MYLOTARG dosage: unknown. During the same period patient was treated with PLATELETS. Patient recovered.
Mylotarg Side Effects Report #5280107-X
MYLOTARG problem was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, weighting 134.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, ascites, febrile neutropenia, hepatomegaly, malaise, neutrophil count decreased, platelet count decreased, weight increased. MYLOTARG dosage: unknown. During the same period patient was treated with POLYMYXIN B SULPHATE, FLUCONAZOLE, FAMOTIDINE, MUCOSTA, AMLODIN, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #5280338-9
Physician from JAPAN reported MYLOTARG problem on Mar 20, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: chills, condition aggravated, disseminated intravascular coagulation, hypoxia, neutrophil count decreased, pyrexia. MYLOTARG dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MEROPEN, OMEGACIN. Patient recovered.
Mylotarg Side Effects Report #5281844-3
MYLOTARG problem was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, condition aggravated, neutropenia, perianal abscess, platelet count decreased, white blood cell count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with KEITEN, FUNGUARD, MEROPEN, ZOVIRAX, FUNGIZONE, VANCOMYCIN, TARGOCID. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5283671-X
Physician from JAPAN reported MYLOTARG problem on Mar 25, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sedation and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, cellulitis, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, herpes simplex, hypoalbuminaemia, mouth haemorrhage. MYLOTARG dosage: unknown. During the same period patient was treated with NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, BAKTAR, MIDAZOLAM, VFEND. Patient was hospitalized. Patient died on 10/15/2006.
Mylotarg Side Effects Report #5283730-1
MYLOTARG problem was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, insomnia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood pressure diastolic increased, c-reactive protein increased, condition aggravated, fibrin degradation products increased, nausea. MYLOTARG dosage: unknown. During the same period patient was treated with GASTER, PRORENAL, ACLARUBICIN HYDROCHLORIDE, MUCOSTA, ZOLPIDEM TARTRATE, CYTARABINE, ETODOLAC, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #5283739-8
Physician from JAPAN reported MYLOTARG problem on Mar 23, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, emphysema and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, peptic ulcer, thrombocytopenia. MYLOTARG dosage: unknown. During the same period patient was treated with MUCOSTA, BAKTAR, POLYMYXIN B SULPHATE, CLARITHROMYCIN, ZANTAC, DIFLUCAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5283746-5
MYLOTARG problem was reported by a Physician from JAPAN on Mar 23, 2007. Female patient, 37 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, venoocclusive liver disease. MYLOTARG dosage: unknown. During the same period patient was treated with HEPARIN, FUNGUARD, BUSULFAN, OMEPRAL. Patient died on 06/21/2006.
Mylotarg Side Effects Report #5284200-7
Physician from JAPAN reported MYLOTARG problem on Mar 22, 2007. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, herpes simplex, pyrexia, tumour lysis syndrome, white blood cell count decreased. MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, VFEND, TARGOCID, ISEPACIN, DALACIN, GASTER. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5284681-9
MYLOTARG problem was reported by a Physician from JAPAN on Mar 23, 2007. Female patient, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5284850-8
Health Professional from UNITED STATES reported MYLOTARG problem on Mar 26, 2007. Male patient, 75 years of age, weighting 197.2 lb, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, respiratory distress. MYLOTARG dosage: unknown. During the same period patient was treated with PLATELETS. Patient died on 04/06/2006.
Mylotarg Side Effects Report #5286578-7
MYLOTARG problem was reported by a Physician from JAPAN on Mar 27, 2007. Male patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, blood urea increased, c-reactive protein increased, condition aggravated, performance status decreased, pneumonia, white blood cell count increased. MYLOTARG dosage: unknown. During the same period patient was treated with CYTARABINE, MEROPEN, AMIKACIN, GASTER, PREDONINE, DIFLUCAN, BAKTAR. Patient died on 02/16/2007.
Mylotarg Side Effects Report #5286743-9
Physician from JAPAN reported MYLOTARG problem on Mar 27, 2007. Male patient, 44 years of age, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: pneumonia. MYLOTARG dosage: unknown. Patient died on 03/27/2007.
Mylotarg Side Effects Report #5287665-X
MYLOTARG problem was reported by a Physician from JAPAN on Mar 27, 2007. Male patient, weighting 121.3 lb, was diagnosed with acute leukaemia, prophylaxis, sepsis, cytomegalovirus viraemia, cholestasis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, chronic graft versus host disease, condition aggravated, disseminated intravascular coagulation, hyperbilirubinaemia, oxygen saturation decreased, platelet count decreased, renal failure acute, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with ACYCLOVIR, MEROPEN, VFEND, TARGOCID, CIPROFLOXACIN, GANCICLOVIR. Patient recovered.
Mylotarg Side Effects Report #5288513-4
Physician from JAPAN reported MYLOTARG problem on Mar 27, 2007. Female patient, 51 years of age, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. MYLOTARG dosage: unknown. Patient died on 03/27/2007.
Mylotarg Side Effects Report #5288523-7
MYLOTARG problem was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 39.68 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac failure, disseminated intravascular coagulation, dyspnoea, hepatic function abnormal, hypoxia, pericardial effusion, pleural effusion, tumour lysis syndrome. MYLOTARG dosage: unknown. During the same period patient was treated with NOVANTRONE, LENOGRASTIM, IDARUBICIN, FRAGMIN. Patient was hospitalized. Patient died on 03/29/2006.
Mylotarg Side Effects Report #5289593-2
Physician from JAPAN reported MYLOTARG problem on Mar 27, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anorexia, blood pressure decreased, haemorrhagic diathesis, hepatic function abnormal, neutrophil count decreased, platelet count decreased, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with ITRACONAZOLE, FAMOTIDINE, DALTEPARIN, ZOVIRAX, BAKTAR, BENET, ALLORINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5289610-X
MYLOTARG problem was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood urea increased, cerebral haemorrhage, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia, sepsis. MYLOTARG dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ALTAT, SELBEX, GLUCOSEECTION, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/27/2007.
Showing 1-50 of 442 Next >
Drug Information: Gemtuzumab Ozogamicin Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607075.html
jem tooz' oo mab oh'' zoe ga mye' sinIMPORTANT WARNING:
| Gemtuzumab ozogamicin injection should be given in a hospital or medical facility under the supervision of a doctor who is experienced in treating people who have leukemia.Gemtuzumab ozogamicin injection should not be given with other chemotherapy medications.Gemtuzumab ozogamicin injection causes a severe decrease in the number of all types of blood cells in your blood. This may cause certain symptoms and may increase the risk that you will develop a serious infection. If you experience any of the following symptoms, call your doctor immediately: pale skin, excessive tiredness, shortness of breath, dizziness, fast heartbeat, unusual bruising or bleeding, nosebleeds, black or tarry stool, blood in the urine, excessive vaginal bleeding, or signs of infection such as sore throat, fever, cough, and chills.Gemtuzumab ozogamicin injection may cause serious or fatal allergic reactions which usually occur during the infusion of the medication or within 24 hours of receiving a dose. The risk that you will experience a serious allergic reaction is greater if you have lung disease or if you have a large number of white blood cells in your blood. You may be given medication or other treatment to decrease the number of white blood cells in your blood before you receive gemtuzumab ozogamicin. You also may receive certain medications before and during your infusion to prevent an allergic reaction. Your doctor will watch you carefully while you are receiving gemtuzumab ozogamicin and for at least 4 hours afterward. If you experience any of the following symptoms, tell your doctor immediately: hives; rash; itching; swelling of the eyes, face, mouth, tongue, throat, arms, hands, feet, ankles, or lower legs; hoarseness; difficulty breathing or swallowing; shortness of breath; fast, breathing; wheezing; coughing; pale or bluish skin; anxiety or restlessness; excessive sweating; fever; or chills.Gemtuzumab ozogamicin injection may cause serious or fatal liver damage. Tell your doctor if you have had or will be having a stem cell transplant (procedure that replaces diseased bone marrow with healthy bone marrow) and if you have or have ever had liver disease. If you experience any of the following symptoms, tell your doctor immediately: fast weight gain, pain in the upper right area of the stomach, swelling of the stomach, or yellowing of the skin or eyes.Talk to your doctor about the risks of using gemtuzumab ozogamicin injection. |
Why is this medication prescribed?
Gemtuzumab ozogamicin injection is used to treat a certain type of leukemia (cancer that begins in the cells of the bone marrow) in people who are at least 60 years old, whose disease has come back after treatment with a different medication, and who cannot be treated with other medications. Gemtuzumab ozogamicin injection is in a class of medications called antineoplastic agents. It works by killing cancer cells.
How should this medicine be used?
Gemtuzumab ozogamicin comes as a powder to be mixed with water and slowly injected into a vein over 2 hours in a hospital or medical facility. It is usually given as 2 doses spaced 14 days apart.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before using gemtuzumab ozogamicin injection,
- tell your doctor and pharmacist if you are allergic to gemtuzumab ozogamicin injection or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had any of the conditions mentioned in the IMPORTANT WARNING section of if you have kidney disease.
- tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant during your treatment with gemtuzumab ozogamicin. Talk to your doctor about methods of birth control that will work for you. If you become pregnant while using Gemtuzumab ozogamicin injection, call your doctor. Gemtuzumab ozogamicin injection may harm the fetus.
- do not breast-feed during your treatment with gemtuzumab ozogamicin. injection.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are being treated with gemtuzumab ozogamicin injection.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
The medical staff will give you your medication as scheduled.
What side effects can this medication cause?
Gemtuzumab ozogamicin injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- nausea
- vomiting
- cold sores
- sores in mouth or throat
- constipation
- diarrhea
- heartburn
- loss of appetite
- headache
- back pain
- weakness
- depression
- difficulty falling asleep or staying asleep
Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- cloudy urine
- irregular heartbeat
- muscle or joint pain
- loss of muscle control
- seizures
Gemtuzumab ozogamicin injection may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
What storage conditions are needed for this medicine?
This medication will be stored in the hospital or medical facility where you receive each dose.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to gemtuzumab ozogamicin injection.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|